Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: Trastuzumab|DRUG: Bevacizumab|DRUG: Epirubicin|DRUG: Cyclophosphamid
Sponsor: West German Study Group
Collaborators: Roche Pharma AG|Sanofi